El-Sayed Profile, FDA Peptides in STAT+ Newsletter — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Abdul El-Sayed is the Democratic Senate candidate in Michigan, and the newsletter's lead section is titled "El-Sayed's clapback," with the headline tying that response to RFK Jr.
- Anil Oza's profile describes El-Sayed as a second-generation immigrant, a federally funded health equity researcher, a former local public health director and an evangelist for single-payer health care.
- FDA's "enforcement discretion" on peptides is the issue's second headline item, but the open excerpt carries no supporting detail on it.
- D.C. Diagnosis is STAT's twice-weekly newsletter on the politics and policy of health and medicine, sent on Tuesdays and Thursdays.
- STAT reserves the full article for STAT+ subscribers, leaving only the profile paragraph and newsletter framing publicly visible.
- John Wilkerson is the named recipient of news tips via Signal, alongside a tips email address listed in the issue.
Why it matters: The substantiated takeaway from the open excerpt is how El-Sayed is being positioned in Michigan's Senate race: second-generation immigrant, federally funded health equity researcher, former local public health director and single-payer evangelist. Those four descriptors are the entire public record of his positioning, while FDA's peptide-enforcement item stays subscriber-only.
Ask SkimNews
